In 2024, West Pharmaceutical Services completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, West Pharmaceutical Services has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Scope 1 | 31,327a | 31,017a | 31,371b | |
Total Scope 2 | ||||
Unspecified Calculation Method | 66,576a | 73,173a | 91,563b | |
Total Scope 3 | N/A | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 10.8278a | 10.515a | 10.8667b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of West Pharmaceutical Services amounted to 97,903 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of West Pharmaceutical Services decreased by 6.03%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2024, the total Scope 1 emissions of West Pharmaceutical Services were 31,327 metric tons of CO₂ equivalent (tCO₂e).a
Since 2021, West Pharmaceutical Services's Scope 1 emissions have remained relatively, stable, indicating that West Pharmaceutical Services's emissions have plateaued with no significant change in its operational footprint.ac
Compared to the previous year (2023), West Pharmaceutical Services's Scope 1 emissions remained relatively stable, indicating that West Pharmaceutical Services's emissions have plateaued with no significant change in its operational footprint.a
In 2024, West Pharmaceutical Services reported Scope 2 greenhouse gas (GHG) emissions of 66,576 tCO₂e without specifying the calculation method.a
Since 2021, West Pharmaceutical Services's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 31.31%, reflecting a declining long-term trend in Scope 2 emissions over time.ac
Compared to the previous year (2023), West Pharmaceutical Services's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that West Pharmaceutical Services's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, West Pharmaceutical Services reported its Scope 2 emissions using an unspecified methodology.a
In 2024, West Pharmaceutical Services reported Scope 1 greenhouse gas (GHG) emissions of 31,327 tCO₂e and total revenues of USD 2,893 millions. This translates into an emissions intensity of 10.83 tCO₂e per millions USD.a
In 2024, West Pharmaceutical Services reported a Scope 1 emissions intensity of 10.83 tCO₂e per millions USD. Compared to the peer group median of 4.47, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, West Pharmaceutical Services ranked 21 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places West Pharmaceutical Services among the least efficient performers, with one of the highest emissions intensities in its sector.a